Dr. Jeffrey Gregg Levine, MD Internal Medicine - Gastroenterology Medicare: Not Enrolled in Medicare Practice Location: 10 Cherry Ct, Lafayette Hill, PA 19444 Phone: 610-564-3011 Fax: 812-461-0966 |
Cynthia L Calbot Sczepanski, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 443 Germantown Pike, Lafayette Hill, PA 19444 Phone: 484-342-3000 Fax: 484-342-3010 |
Veena Srinath Devarakonda, M.D, Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 9317 Eagleview Dr, Lafayette Hill, PA 19444 Phone: 215-432-5321 |
Dr. Jessica Nicole Fields, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 633 Germantown Pike, Floor 2, Lafayette Hill, PA 19444 Phone: 484-576-3705 Fax: 484-727-9983 |
Hannah Koh Chung, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 443 Germantown Pike, Lafayette Hill, PA 19444 Phone: 484-342-3000 Fax: 484-342-3010 |
News Archive
An international team of researchers, led by Mark E. Davis at Caltech, has succeeded in making the first chiral molecular sieves. This discovery opens new areas of investigation in both chemistry and biology, and has broad implications for pharmaceutical companies and other specialized chemical manufacturers.
An Iowa State University team of researchers has developed a type of hybrid proteins that can make double-strand DNA breaks at specific sites in living cells, possibly leading to better gene replacement and gene editing therapies.
The Los Angeles Times: New prostate cancer screening guidelines issued Wednesday by the American Cancer Society "emphasize that physicians should better educate men about both the risks and benefits of using the PSA test for screening. They also call for cutbacks in the use of digital rectal exams to find tumors and recommend the end of mass prostate-screening programs at health fairs and other sites."
Endo Pharmaceuticals announced today that its partners, Teikoku Seiyaku Co., Ltd. and Teikoku Pharma USA, have received a Paragraph IV Certification Notice from Mylan Technologies advising of the filing of an Abbreviated New Drug Application for a generic version of LIDODERM.
› Verified 4 days ago